FDA rejects Replimune cancer therapy, saying company didn't resolve trial doubts
FDA驳回Replimune的溶瘤病毒癌症疗法，称其未能消除对试验的疑虑

The FDA has once again rejected Replimune’s oncolytic virus therapy to treat advanced melanoma.
美国食品药品监督管理局(FDA)再次拒绝了Replimune的溶瘤病毒疗法用于治疗晚期黑色素瘤。